共 108 条
[1]
Mazzaferri EL(1994)Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am J Med 97 418-428
[2]
Jhiang SM(2001)Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer J Clin Endocrinol Metab 86 1447-1463
[3]
Mazzaferri EL(2005)The evolving role of 131I for the treatment of differentiated thyroid carcinoma J Nucl Med 46 28S-37S
[4]
Kloos RT(2004)Clinical review 170: a systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer J Clin Endocrinol Metab 89 3668-3676
[5]
Robbins RJ(2007)131I activity for remnant ablation in patients with differentiated thyroid cancer: a systematic review J Clin Endocrinol Metab 92 28-38
[6]
Schlumberger MJ(2015)Low versus high radioiodine activity to ablate the thyroidafter thyroidectomy for cancer: a meta-analysis of randomized controlled trials Endocrine 48 96-105
[7]
Sawka AM(1996)Prospective randomized clinical trial to evaluate the optimal dose of 131I for remnant ablation in patients with differentiated thyroid carcinoma Cancer 77 2574-2580
[8]
Thephamongkhol K(1987)High or low dose radioiodine ablation of thyroid remnants? Eur J Nucl Med 12 500-502
[9]
Brouwers M(1991)Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer J Nucl Med 32 252-254
[10]
Thabane L(2012)Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer Nucl Med Commun 33 268-274